BCP
CVS icon

Berkeley Capital Partners’s CVS Health CVS Stock Holding History

Berkeley Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,771
Closed -$535K – 130
2022
Q2 		$535K Sell
5,771
-198
-3% -$19.3K 0.22% 84
2022
Q1 		$604K Sell
5,969
-1,015
-15% -$107K 0.24% 85
2021
Q4 		$721K Sell
6,984
-910
-12% -$84.1K 0.3% 54
2021
Q3 		$670K Sell
7,894
-162
-2% -$13.6K 0.31% 50
2021
Q2 		$672K Sell
8,056
-546
-6% -$44.7K 0.3% 50
2021
Q1 		$647K Sell
8,602
-1,006
-10% -$73.3K 0.31% 53
2020
Q4 		$656K Sell
9,608
-557
-5% -$36.2K 0.34% 48
2020
Q3 		$594K Sell
10,165
-1,050
-9% -$65.3K 0.36% 43
2020
Q2 		$729K Sell
11,215
-4,402
-28% -$277K 0.45% 39
2020
Q1 		$927K Sell
15,617
-3,691
-19% -$246K 0.63% 29
2019
Q4 		$1.43M Sell
19,308
-1,252
-6% -$87.9K 0.73% 24
2019
Q3 		$1.3M Buy
20,560
+2,223
+12% +$132K 0.68% 26
2019
Q2 		$999K Buy
18,337
+1,380
+8% +$74.3K 0.47% 40
2019
Q1 		$915K Buy
16,957
+2,251
+15% +$139K 0.45% 47
2018
Q4 		$964K Buy
+14,706
New +$1.1M 0.54% 35

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Berkeley Capital Partners's CVS Position: Q3 2022 in Review

Berkeley Capital Partners sold out of CVS Health (CVS) in Q3 2022, closing a stake of 5,771 shares — an estimated $535K sold.

Berkeley Capital Partners first reported a position in CVS in Q4 2018 and held it in 15 quarters. The position peaked at $1.43M in Q4 2019. 2,325 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • Berkeley Capital Partners reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
  • Berkeley Capital Partners sold 5,771 CVS Health shares in Q3 2022, an estimated $535K.
  • Berkeley Capital Partners first reported a position in CVS Health in Q4 2018 and held it in 15 quarters.
  • Berkeley Capital Partners's CVS Health position peaked at $1.43M in Q4 2019.
  • 2,325 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Berkeley Capital Partners's 13F filing for Q3 2022, filed 4 Nov 2022.